Patent: 10,105,346
✉ Email this page to a colleague
Summary for Patent: 10,105,346
| Title: | Isoflavonoid compounds and methods for the treatment of cancer |
| Abstract: | Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions. |
| Inventor(s): | Jeoffreys; George (Baulkham Hills, AU), Johnson; Alison (Drummoyne, AU), Heaton; Andrew (Alexandria, AU), Moreno; Ofir (Poway, CA) |
| Assignee: | MEI PHARMA, INC. (San Diego, CA) |
| Application Number: | 15/456,182 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,105,346
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2030-11-01 |
| Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2030-11-01 |
| Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 02/26/2004 | ⤷ Try a Trial | 2030-11-01 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
